Technology and Health Leaders Join Myriad Genetics, Advance in Senior Roles to Drive Key Enterprise Functions, Transformation and Growth Initiatives


You May Also Like

Oncobiologics to Present at the World Biosimilar Congress 2017

CRANBURY, N.J., May 09, 2017 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS), a clinical-stage biopharmaceutical ...

Enzymotec Ltd. Reports Third Quarter 2015 Results

Earns non-GAAP $0.08 and GAAP $0.07 per Diluted Share and Generates $4.7 Million in ...